PubMed for id: 410738

Year	Number of Results
1993	2
1999	1
2001	1
2002	2
2005	1
2009	3
2010	1
2016	1
2017	11
2018	2
2024	0

1

Analysis of the binding sites of vitamin D 1α-hydroxylase (CYP27B1) and vitamin D 24-hydroxylase (CYP24A1) for the design of selective CYP24A1 inhibitors: Homology modelling, molecular dynamics simulations and identification of key binding requirements.

Taban IM, Zhu J, DeLuca HF, Simons C. Taban IM, et al. Bioorg Med Chem. 2017 Oct 15;25(20):5629-5636. doi: 10.1016/j.bmc.2017.08.036. Epub 2017 Aug 22. Bioorg Med Chem. 2017. PMID: 28886997

2

CYP24A1 Mutation in a Girl Infant with Idiopathic Infantile Hypercalcemia.

Madsen JOB, Sauer S, Beck B, Johannesen J. Madsen JOB, et al. J Clin Res Pediatr Endocrinol. 2018 Mar 1;10(1):83-86. doi: 10.4274/jcrpe.4841. Epub 2017 Sep 6. J Clin Res Pediatr Endocrinol. 2018. PMID: 28874334 Free PMC article.

3

Association between CYP24A1 polymorphisms and the risk of colonic polyps and colon cancer in a Chinese population.

Chen XQ, Mao JY, Li WB, Li J, Yang H, Qian JM, Li JN. Chen XQ, et al. World J Gastroenterol. 2017 Jul 28;23(28):5179-5186. doi: 10.3748/wjg.v23.i28.5179. World J Gastroenterol. 2017. PMID: 28811712 Free PMC article.

4

Vitamin D Activity and Metabolism in Bone.

Anderson PH. Anderson PH. Curr Osteoporos Rep. 2017 Oct;15(5):443-449. doi: 10.1007/s11914-017-0394-8. Curr Osteoporos Rep. 2017. PMID: 28808890 Review.

5

Synthesis, molecular modelling and CYP24A1 inhibitory activity of novel of (E)-N-(2-(1H-imidazol-1-yl)-2-(phenylethyl)-3/4-styrylbenzamides.

Taban IM, Zhu J, DeLuca HF, Simons C. Taban IM, et al. Bioorg Med Chem. 2017 Aug 1;25(15):4076-4087. doi: 10.1016/j.bmc.2017.05.055. Epub 2017 May 29. Bioorg Med Chem. 2017. PMID: 28601511 Free article.

6

Cytochrome P450 diversity in the tree of life.

Nelson DR. Nelson DR. Biochim Biophys Acta Proteins Proteom. 2018 Jan;1866(1):141-154. doi: 10.1016/j.bbapap.2017.05.003. Epub 2017 May 11. Biochim Biophys Acta Proteins Proteom. 2018. PMID: 28502748 Free PMC article.

7

Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases.

Pronicka E, Ciara E, Halat P, Janiec A, Wójcik M, Rowińska E, Rokicki D, Płudowski P, Wojciechowska E, Wierzbicka A, Książyk JB, Jacoszek A, Konrad M, Schlingmann KP, Litwin M. Pronicka E, et al. J Appl Genet. 2017 Aug;58(3):349-353. doi: 10.1007/s13353-017-0397-2. Epub 2017 May 3. J Appl Genet. 2017. PMID: 28470390 Free PMC article.

8

CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations.

Hawkes CP, Li D, Hakonarson H, Meyers KE, Thummel KE, Levine MA. Hawkes CP, et al. J Clin Endocrinol Metab. 2017 May 1;102(5):1440-1446. doi: 10.1210/jc.2016-4048. J Clin Endocrinol Metab. 2017. PMID: 28324001 Free PMC article.

9

Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.

Slominski AT, Brożyna AA, Zmijewski MA, Jóźwicki W, Jetten AM, Mason RS, Tuckey RC, Elmets CA. Slominski AT, et al. Lab Invest. 2017 Jun;97(6):706-724. doi: 10.1038/labinvest.2017.3. Epub 2017 Feb 20. Lab Invest. 2017. PMID: 28218743 Free PMC article. Review.

10

CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations.

Carpenter TO. Carpenter TO. J Steroid Biochem Mol Biol. 2017 Oct;173:337-340. doi: 10.1016/j.jsbmb.2017.01.006. Epub 2017 Jan 16. J Steroid Biochem Mol Biol. 2017. PMID: 28093352 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year